Infections and inflammatory diseases as risk factors for venous thrombosis
- 1 January 2012
- journal article
- review article
- Published by Georg Thieme Verlag KG in Thrombosis and Haemostasis
- Vol. 107 (05) , 827-837
Abstract
Summary: Inflammation and venous thrombosis are intertwined. Only in the recent 15 years clinical epidemiological studies have focussed on inflammatory or infectious diseases as risk factors for venous thrombosis. Although a few reviews and many case reports or studies on these topic has been written, a review reporting relative or absolute risks for venous thrombosis has not been published yet. We performed a systematic review using Medline, Pubmed and Embase and found 31 eligible articles. Inflammatory bowel disease, ANCA-associated vasculitis, infections in general and more specifically, human immunodeficiency virus, pneumonia and urinary tract infections are associated with an increased risk of venous thrombosis.Keywords
This publication has 64 references indexed in Scilit:
- Risk factors for venous thrombosis – current understanding from an epidemiological point of viewBritish Journal of Haematology, 2010
- Risk of venous thromboembolism with rheumatoid arthritisThrombosis and Haemostasis, 2009
- Risk Factors for Venous Thromboembolism in Hospitalized Patients With Acute Medical IllnessArchives of internal medicine (1960), 2004
- Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?Gut, 2004
- Vascular Thrombosis and Acute Cytomegalovirus Infection in Immunocompetent Patients: Report of 2 Cases and Literature ReviewClinical Infectious Diseases, 2003
- Anticardiolipin antibodies, free protein S levels and thrombosis: a survey in a selected population of rheumatoid arthritis patientsRheumatology, 1999
- Venous thrombosis: a multicausal diseaseThe Lancet, 1999
- C-reactive protein induces human peripheral blood monocytes to synthesize tissue factorBlood, 1993
- Coronary lesions in young HIV-positive subjects at necropsyThe Lancet, 1992
- Activation of Coagulation after Administration of Tumor Necrosis Factor to Normal SubjectsNew England Journal of Medicine, 1990